VANGL2 and breast carcinoma: We determined that Wnt5a-mediated migration is ablated in VANGL2 knockdown breast cancer cells (Fig. 1g), demonstrating that Wnt5a specifically activates Vangl-dependent Wnt/PCP signaling in breast cancer cells.